Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea. (2020). SKIN The Journal of Cutaneous Medicine, 4(5), s54. https://doi.org/10.25251/skin.4.supp.53